205 related articles for article (PubMed ID: 30215155)
1. A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?
Filippelli E; Barone S; Granata A; Nisticò R; Valentino P
Neurol Sci; 2019 Jan; 40(1):195-197. PubMed ID: 30215155
[No Abstract] [Full Text] [Related]
2. Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis.
Sansone V; Saperstein DS; Barohn RJ; Meola G
Muscle Nerve; 2004 Nov; 30(5):679-80. PubMed ID: 15389657
[No Abstract] [Full Text] [Related]
3. [A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis].
Sakuma H; Shimazaki S; Saito H; Ohuchi M
Rinsho Shinkeigaku; 2001; 41(4-5):179-83. PubMed ID: 11676158
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.
Lee I; Sanders D
Muscle Nerve; 2021 Oct; 64(4):385-387. PubMed ID: 34287983
[No Abstract] [Full Text] [Related]
5. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance.
Lane RJ; Roncaroli F; Charles P; McGonagle DG; Orrell RW
Neuromuscul Disord; 2012 Feb; 22(2):122-8. PubMed ID: 21872471
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
[TBL] [Abstract][Full Text] [Related]
8. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.
Rajakulendran S; Viegas S; Spillane J; Howard RS
J Neurol; 2012 Dec; 259(12):2736-9. PubMed ID: 22955633
[No Abstract] [Full Text] [Related]
9. Seronegative myasthenia gravis: the importance of clusters of acetylcholine receptors.
Rowland LP
Arch Neurol; 2012 Aug; 69(8):965-6. PubMed ID: 22689131
[No Abstract] [Full Text] [Related]
10. Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
Sanders DB; Burns TM; Cutter GR; Massey JM; Juel VC; Hobson-Webb L;
Muscle Nerve; 2014 Apr; 49(4):483-6. PubMed ID: 23835683
[TBL] [Abstract][Full Text] [Related]
11. An update on laboratory diagnosis in myasthenia gravis.
Oger J; Frykman H
Clin Chim Acta; 2015 Sep; 449():43-8. PubMed ID: 26238187
[TBL] [Abstract][Full Text] [Related]
12. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
[TBL] [Abstract][Full Text] [Related]
13. Facial and bulbar muscle atrophy in acetylcholine receptor antibody-positive myasthenia gravis.
Grativvol RS; Silva AM; Guedes BF; Estephan EP; Mendonça RH; Zambon AA; Heise CO; Zanoteli E
Arq Neuropsiquiatr; 2017 Mar; 75(3):197-198. PubMed ID: 28355331
[No Abstract] [Full Text] [Related]
14. Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation.
Witoonpanich R; Dejthevaporn C; Sriphrapradang A; Pulkes T
Clin Neurophysiol; 2011 Sep; 122(9):1873-7. PubMed ID: 21419697
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies.
Evoli A; Alboini PE; Damato V; Iorio R
Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957
[No Abstract] [Full Text] [Related]
16. Diagnostic sensitivity of the laboratory tests in myasthenia gravis.
Oh SJ; Kim DE; Kuruoglu R; Bradley RJ; Dwyer D
Muscle Nerve; 1992 Jun; 15(6):720-4. PubMed ID: 1324429
[TBL] [Abstract][Full Text] [Related]
17. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
[TBL] [Abstract][Full Text] [Related]
18. Facioscapulohumeral muscular dystrophy and myasthenia gravis co-existing in the same patient: a case report.
McGonigal A; Thomas AM; Petty RK
J Neurol; 2002 Feb; 249(2):219-20. PubMed ID: 11985390
[No Abstract] [Full Text] [Related]
19. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis exacerbation in association with antibody overshoot following plasmapheresis.
Ching J; Richards D; Lewis RA; Li Y
Muscle Nerve; 2021 Oct; 64(4):483-487. PubMed ID: 34076268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
